To retain target biotech company employees—arguably as vital to success as the pipeline being acquired—biopharmas need talent strategies that focus on three key areas.
Education
- PhD, industrial and operations engineering, University of Michigan
- MSE, industrial and operations engineering, University of Michigan
- BSE, industrial and operations engineering, University of Michigan
Megan DeFauw is a core member of Boston Consulting Group’s Health Care and Operations practices. She focuses on biopharma and medtech manufacturing and supply chain. Since joining BCG in 2011, Megan has worked extensively in strategy and operations topics including network design, quality, organization design, large-scale transformation, post-merger integration, and divestitures. Megan leads the firm’s work in quality for North America, as well as for cost transformation in health care operations.
Megan has worked with pharmaceutical and medtech clients across all phases of acquisitions and divestitures, as well as manufacturing network strategy and redesign, operations transformation, and quality remediation and transformation.
